Addex Therapeutics, a clinical-stage biopharmaceutical company, has reported its Q1 2024 financial results and provided a corporate update. The company…
Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) has released its financial results for the first quarter of 2024, showing significant improvements…
